Mercury Bio Executives to Present Novel, Disruptive Drug Delivery Platform at 2024 Biotech Showcase

Investor Meetings Now Being Scheduled during J.P. Morgan 42nd Annual Healthcare Conference SANTA FE, N.M., Dec. 20, 2023 /PRNewswire/ — Mercury Bio, (www.mercurybio.com) a Santa Fe, NM–based biotech company commercializing an innovative and highly disruptive drug delivery platform, today…